Developmental Effects of Infant Formula Supplemented With LCPUFA

Not Applicable

Completed

• Conditions: Cognitive Development; Growth
• Interventions: Other: Control; Other: DHA and ARA

• Registration Number: NCT00753818
• Lead Sponsor: Mead Johnson Nutrition

Brief Summary

The purpose of this study is to compare the effects on visual development, growth, cognitive development, tolerance, and blood chemistry parameters in term infants fed one of four study formulas containing various levels of DHA and ARA.

Detailed Description

Not available

Study Timeline

• Status Verified: 2008-09
• Study First Submitted: 2008-09-16
• Study First Submitted QC: 2008-09-16
• Last Update Submitted: 2008-09-16
• Study First Posted: 2008-09-17
• Last Update Posted: 2008-09-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• healthy, term, formula fed infants from 1-5 days of age

Exclusion Criteria

• history of disease that effects normal growth and development
• breast fed, or formula intolerance

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
4	Control	Control
1	DHA and ARA	-
2	DHA and ARA	-
3	DHA and ARA	-

Primary Outcome Measures

Name	Time	Method
visual development

Secondary Outcome Measures

Name	Time	Method
Cognitive development

Trial Locations

Locations (2)

The University of Texas Southwestern Medical Center at Dallas; 🇺🇸 Dallas, Texas, United States

The University of Kansas Medical Center; 🇺🇸 Kansas City, Kansas, United States